Fuller & Thaler Asset Management’s Select Medical SEM Stock Holding History

Fuller & Thaler Asset Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-119	Closed	-$1.81K	–	599
2025 Q2	$1.81K	Hold	119	–	–	﹤0.01%	590
2025 Q1	$1.99K	Hold	119	–	–	﹤0.01%	573
2024 Q4	$2.24K	Sell	119 -126	-51%	-$2.43K	﹤0.01%	583
2024 Q3	$4.6K	Hold	245	–	–	﹤0.01%	536
2024 Q2	$4.63K	Hold	245	–	–	﹤0.01%	526
2024 Q1	$3.98K	Hold	245	–	–	﹤0.01%	515
2023 Q4	$3.1K	Hold	245	–	–	﹤0.01%	504
2023 Q3	$3.34K	Hold	245	–	–	﹤0.01%	497
2023 Q2	$4.21K	Hold	245	–	–	﹤0.01%	486
2023 Q1	$3.41K	Sell	245 -1,440	-85%	-$21.2K	﹤0.01%	502
2022 Q4	$23K	Sell	1,685 -26	-2%	-$336	﹤0.01%	441
2022 Q3	$20K	Sell	1,711 -2,105,751	-100%	-$29.9M	﹤0.01%	447
2022 Q2	$26.8M	Sell	2,107,462 -1,243,527	-37%	-$16M	0.18%	156
2022 Q1	$43.3M	Sell	3,350,989 -1,076,317	-24%	-$14.2M	0.26%	127
2021 Q4	$70.1M	Buy	4,427,306 +444,759	+11%	+$7.59M	0.41%	77
2021 Q3	$77.6M	Sell	3,982,547 -928	-0%	-$18.4K	0.5%	61
2021 Q2	$90.7M	Buy	3,983,475 +56,411	+1%	+$1.17M	0.59%	54
2021 Q1	$72.2M	Buy	3,927,064 +35,886	+0.9%	+$588K	0.51%	63
2020 Q4	$58M	Buy	3,891,178 +1,439,298	+59%	+$18.8M	0.54%	64
2020 Q3	$27.5M	Buy	2,451,880 +1,357,991	+124%	+$13.4M	0.35%	89
2020 Q2	$8.68M	Sell	1,093,889 -176,244	-14%	-$1.46M	0.11%	176
2020 Q1	$10.3M	Sell	1,270,133 -128,159	-9%	-$1.52M	0.17%	129
2019 Q4	$17.6M	Buy	1,398,292 +230,332	+20%	+$2.48M	0.2%	134
2019 Q3	$10.4M	Buy	1,167,960 +204,254	+21%	+$1.79M	0.12%	154
2019 Q2	$8.24M	Buy	+963,706	New	+$7.61M	0.1%	169
2015 Q3	–	Sell	-334	Closed	-$3K	–	746
2015 Q2	$3K	Buy	+334	New	+$2.81K	﹤0.01%	624

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fuller & Thaler Asset Management's SEM Position: Q3 2025 in Review

Fuller & Thaler Asset Management sold out of Select Medical (SEM) in Q3 2025, closing a stake of 119 shares — an estimated $1.81K sold.

Fuller & Thaler Asset Management first reported a position in SEM in Q2 2015 and held it in 26 quarters. The position peaked at $90.7M in Q2 2021. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

Fuller & Thaler Asset Management reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
Fuller & Thaler Asset Management sold 119 Select Medical shares in Q3 2025, an estimated $1.81K.
Fuller & Thaler Asset Management first reported a position in Select Medical in Q2 2015 and held it in 26 quarters.
Fuller & Thaler Asset Management's Select Medical position peaked at $90.7M in Q2 2021.
268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.